AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pemgli-MP2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Superlative Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Pemgli-MP2 Tablet ER

Metformin-glimepiride extended-release tablets manage blood glucose levels in adults with type 2 diabetes. This dual-action medication, used alongside diet and exercise, enhances insulin effectiveness and reduces blood sugar. Always follow your doctor's prescribed dosage and schedule; take it with food to prevent stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; never double the dose. Excessive medication can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia risk increases when combined with other diabetes medications, alcohol, or skipped meals; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your physician of any kidney, liver, or heart conditions before use. Pregnant or lactating individuals require medical consultation. Kidney function will be assessed prior to treatment. Limit alcohol consumption to minimize side effect risk.

Uses of Pemgli-MP2 Tablet ER

Managing Type 2 diabetes

Major Benefits of Pemgli-MP2 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pemgli-MP2 Extended-Release Tablets should be taken with a meal.

Common Side effects of Pemgli-MP2 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Pemgli-MP2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Pemgli-MP2 Tablet ER. Ingest the tablet whole; do not chew, crush, or fracture it. This medication should be administered with a meal.

How Pemgli-MP2 Tablet ER works:

Pemgli-MP2 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Pemgli-MP2 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Pemgli-MP2 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for guidance.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Pemgli-MP2 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Pemgli-MP2 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult your physician for guidance. Pemgli-MP2 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment with this medication.

LiverLiverCAUTION

Patients with hepatic impairment should use Pemgli-MP2 Tablet ER cautiously, potentially requiring dose modification. Consult your physician. Pemgli-MP2 Tablet ER is contraindicated in individuals with severe liver disease.

What if you forget to take Pemgli-MP2 Tablet ER :

Should you forget a Pemgli-MP2 Tablet ER dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Pemgli-MP2 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Pemgli-MP2 Tablet ER

Consuming alcohol while taking Pemgli-MP2 Tablet ER is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Consult your doctor before taking Pemgli-MP2 Tablet ER if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and of all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Metformin, a component of Pemgli-MP2 Tablet ER, can lead to vitamin B12 deficiency with prolonged use due to impaired intestinal absorption.
Pemgli-MP2 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always keep a readily available sugary treat, such as candy or chocolate, on hand.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Pemgli-MP2 Tablet ER
75
MRP 91
17% off